AllianceBernstein’s NRC Health Common Stock NRC Stock Holding History

AllianceBernstein’s Portfolio NRC Stock Details NRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$304K	Sell	16,199 -1,200	-7%	-$20.4K	﹤0.01%	2873
2025 Q4	$327K	Sell	17,399 -1,100	-6%	-$16.6K	﹤0.01%	2871
2025 Q3	$236K	Buy	18,499 +1,100	+6%	+$16.5K	﹤0.01%	3026
2025 Q2	$292K	Buy	17,399 +2,900	+20%	+$39.2K	﹤0.01%	2922
2025 Q1	$186K	Sell	14,499 -300	-2%	-$4.82K	﹤0.01%	2937
2024 Q4	$261K	Hold	14,799	–	–	﹤0.01%	2942
2024 Q3	$338K	Hold	14,799	–	–	﹤0.01%	2858
2024 Q2	$340K	Buy	14,799 +680	+5%	+$21K	﹤0.01%	2866
2024 Q1	$559K	Hold	14,119	–	–	﹤0.01%	2537
2023 Q4	$559K	Sell	14,119 -420	-3%	-$17.6K	﹤0.01%	2558
2023 Q3	$645K	Sell	14,539 -230	-2%	-$10K	﹤0.01%	2446
2023 Q2	$643K	Sell	14,769 -300	-2%	-$13.2K	﹤0.01%	2503
2023 Q1	$656K	Hold	15,069	–	–	﹤0.01%	2430
2022 Q4	$562K	Buy	15,069 +500	+3%	+$19.3K	﹤0.01%	2567
2022 Q3	$580K	Hold	14,569	–	–	﹤0.01%	2574
2022 Q2	$558K	Sell	14,569 -5,060	-26%	-$183K	﹤0.01%	2636
2022 Q1	$778K	Buy	19,629 +5,060	+35%	+$198K	﹤0.01%	2511
2021 Q4	$605K	Hold	14,569	–	–	﹤0.01%	2652
2021 Q3	$614K	Sell	14,569 -300	-2%	-$15.1K	﹤0.01%	2681
2021 Q2	$682K	Hold	14,869	–	–	﹤0.01%	2686
2021 Q1	$696K	Sell	14,869 -900	-6%	-$43.7K	﹤0.01%	2545
2020 Q4	$674K	Sell	15,769 -900	-5%	-$46.2K	﹤0.01%	2464
2020 Q3	$820K	Sell	16,669 -500	-3%	-$27.7K	﹤0.01%	2273
2020 Q2	$999K	Buy	17,169 +900	+6%	+$47.5K	﹤0.01%	2205
2020 Q1	$740K	Sell	16,269 -900	-5%	-$54.1K	﹤0.01%	2174
2019 Q4	$1.13M	Hold	17,169	–	–	﹤0.01%	2234
2019 Q3	$992K	Hold	17,169	–	–	﹤0.01%	2254
2019 Q2	$989K	Buy	17,169 +3,900	+29%	+$180K	﹤0.01%	2315
2019 Q1	$512K	Sell	13,269 -100	-0.7%	-$3.92K	﹤0.01%	2512
2018 Q4	$510K	Buy	13,369 +400	+3%	+$15.4K	﹤0.01%	2472
2018 Q3	$501K	Hold	12,969	–	–	﹤0.01%	2618
2018 Q2	$485K	Buy	12,969 +700	+6%	+$24.4K	﹤0.01%	2623
2018 Q1	$359K	Buy	12,269 +800	+7%	+$26.8K	﹤0.01%	2633
2017 Q4	$428K	Sell	11,469 -700	-6%	-$24.9K	﹤0.01%	2581
2017 Q3	$459K	Sell	12,169 -200	-2%	-$6.28K	﹤0.01%	2601
2017 Q2	$333K	Buy	12,369 +600	+5%	+$14.7K	﹤0.01%	2773
2017 Q1	$232K	Hold	11,769	–	–	﹤0.01%	2806
2016 Q4	$224K	Hold	11,769	–	–	﹤0.01%	2854
2016 Q3	$192K	Buy	11,769 +100	+0.9%	+$1.57K	﹤0.01%	2848
2016 Q2	$160K	Buy	11,669 +800	+7%	+$11.3K	﹤0.01%	2844
2016 Q1	$169K	Hold	10,869	–	–	﹤0.01%	2750
2015 Q4	$174K	Buy	10,869 +200	+2%	+$3.04K	﹤0.01%	2777
2015 Q3	$127K	Sell	10,669 -9,842	-48%	-$131K	﹤0.01%	2853
2015 Q2	$291K	Hold	20,511	–	–	﹤0.01%	2757
2015 Q1	$295K	Hold	20,511	–	–	﹤0.01%	2688
2014 Q4	$287K	Sell	20,511 -200	-1%	-$2.94K	﹤0.01%	2683
2014 Q3	$269K	Hold	20,711	–	–	﹤0.01%	2684
2014 Q2	$290K	Hold	20,711	–	–	﹤0.01%	2689
2014 Q1	$344K	Sell	20,711 -200	-1%	-$3.35K	﹤0.01%	2564
2013 Q4	$394K	Sell	20,911 -1,400	-6%	-$24.6K	﹤0.01%	2538
2013 Q3	$420K	Sell	22,311 -195	-0.9%	-$3.35K	﹤0.01%	2562
2013 Q2	$405K	Buy	+22,506	New	+$359K	﹤0.01%	2591

Other funds holding NRC

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

AllianceBernstein's NRC Position: Q1 2026 in Review

AllianceBernstein reduced its NRC Health Common Stock (NRC) stake by 6.9% in Q1 2026, selling an estimated $20.4K and leaving 16,199 shares worth $304K. The position accounts for ﹤0.01% of the portfolio, ranked #2873.

AllianceBernstein first reported a position in NRC in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.13M in Q4 2019. 121 funds tracked by Wall St. Rank hold NRC as of Q1 2026.

AllianceBernstein held 16,199 shares of NRC Health Common Stock worth $304K as of Q1 2026.
AllianceBernstein sold 1,200 NRC Health Common Stock shares in Q1 2026, an estimated $20.4K.
NRC Health Common Stock made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2873 holding.
AllianceBernstein first reported a position in NRC Health Common Stock in Q2 2013 and has held it in 52 quarters since.
AllianceBernstein's NRC Health Common Stock position peaked at $1.13M in Q4 2019.
121 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.